Exchange: NASDAQ·Updated 08:53 AM EDT

BGLC News

News
all
press releases
BGLC Stock Tumbled Over 13% Today: Why Is VitaGuard Commercialization Agreement Drawing Investor Attention?
The partnership aims to support the planned commercialization of minimal residual disease testing in Southeast Asia.
Stocktwits

Advertisement|Remove ads.